Clinical Trial Update: A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for 7MW3711 in advanced solid tumors is reported, with status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• 7MW3711

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN